Trader consensus on Polymarket implies a 54% probability that the CDC will issue a Level 3 Travel Health Notice—recommending travelers reconsider nonessential travel due to high outbreak risk—for any disease by December 31, 2026, driven primarily by the accelerating U.S. measles outbreak, with over 1,500 confirmed cases reported nationwide as of late March amid multiple state clusters like Texas and South Carolina. Sporadic human H5N1 bird flu infections, including recent clusters in Washington and California, add to concerns over potential escalation, though no sustained person-to-person transmission has been detected. This near-even split reflects scientific uncertainties in outbreak trajectories, vaccination uptake, and international spread thresholds for Level 3 designation. Key tipping points include CDC's weekly Thursday surveillance reports on case counts and epidemiology, plus any signals of H5N1 adaptation from genomic sequencing.